Defining community acquired pneumonia severity on presentation to hospital: an international derivation and validation study

Background: In the assessment of severity in community acquired pneumonia (CAP), the modified British Thoracic Society (mBTS) rule identifies patients with severe pneumonia but not patients who might be suitable for home management. A multicentre study was conducted to derive and validate a practical severity assessment model for stratifying adults hospitalised with CAP into different management groups. Methods: Data from three prospective studies of CAP conducted in the UK, New Zealand, and the Netherlands were combined. A derivation cohort comprising 80% of the data was used to develop the model. Prognostic variables were identified using multiple logistic regression with 30 day mortality as the outcome measure. The final model was tested against the validation cohort. Results: 1068 patients were studied (mean age 64 years, 51.5% male, 30 day mortality 9%). Age ⩾65 years (OR 3.5, 95% CI 1.6 to 8.0) and albumin <30 g/dl (OR 4.7, 95% CI 2.5 to 8.7) were independently associated with mortality over and above the mBTS rule (OR 5.2, 95% CI 2.7 to 10). A six point score, one point for each of Confusion, Urea >7 mmol/l, Respiratory rate ⩾30/min, low systolic(<90 mm Hg) or diastolic (⩽60 mm Hg) Blood pressure), age ⩾65 years (CURB-65 score) based on information available at initial hospital assessment, enabled patients to be stratified according to increasing risk of mortality: score 0, 0.7%; score 1, 3.2%; score 2, 3%; score 3, 17%; score 4, 41.5% and score 5, 57%. The validation cohort confirmed a similar pattern. Conclusions: A simple six point score based on confusion, urea, respiratory rate, blood pressure, and age can be used to stratify patients with CAP into different management groups.

[1]  J. Enders,et al.  Infectious Diseases Society of America. , 1969, Antimicrobial agents and chemotherapy.

[2]  K. Qureshi,et al.  Evaluation of a ten-question mental test in the institutionalized elderly. , 1974, Age and ageing.

[3]  T. Marrie,et al.  Community-acquired pneumonia requiring hospitalization: 5-year prospective study. , 1989, Reviews of infectious diseases.

[4]  M. Leinonen,et al.  Aetiology, outcome and prognostic factors in community-acquired pneumonia requiring hospitalization. , 1990, The European respiratory journal.

[5]  M. Fisch,et al.  Predicting death in patients hospitalized for community-acquired pneumonia. , 1991, Annals of internal medicine.

[6]  M. Fine,et al.  Validation of a pneumonia prognostic index using the MedisGroups Comparative Hospital Database. , 1993, The American journal of medicine.

[7]  B. Lüderitz,et al.  Prognostic analysis and predictive rule for outcome of hospital-treated community-acquired pneumonia. , 1995, The European respiratory journal.

[8]  M. Fine,et al.  Do pulmonary radiographic findings at presentation predict mortality in patients with community-acquired pneumonia? , 1996, Archives of internal medicine.

[9]  R. Rodríguez-Roisín,et al.  Community-acquired pneumonia in the elderly: A multivariate analysis of risk and prognostic factors. , 1996, American journal of respiratory and critical care medicine.

[10]  J. Michel,et al.  Community‐Acquired Pneumonia in Older Patients , 1996, Journal of the American Geriatrics Society.

[11]  G. Town,et al.  Community acquired pneumonia: aetiology and usefulness of severity criteria on admission. , 1996, Thorax.

[12]  M. Fine,et al.  Prognosis and outcomes of patients with community-acquired pneumonia. A meta-analysis. , 1996, JAMA.

[13]  M. Fine,et al.  A prediction rule to identify low-risk patients with community-acquired pneumonia. , 1997, The New England journal of medicine.

[14]  A R Feinstein,et al.  Monte Carlo methods in clinical research: applications in multivariable analysis. , 1997, Journal of investigative medicine : the official publication of the American Federation for Clinical Research.

[15]  E. Stobberingh,et al.  Optimaliseren van het antibioticabeleid in Nederland. II. SWAB-richtlijnen voor antimicrobiele therapie bij thuis opgelopen pneumonie en bij nosocomiale pneumonie , 1998 .

[16]  L. Mandell,et al.  Canadian guidelines for the initial management of community-acquired pneumonia: an evidence-based update by the Canadian Infectious Diseases Society and the Canadian Thoracic Society. The Canadian Community-Acquired Pneumonia Working Group. , 2000, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[17]  W. Lim,et al.  Severity prediction rules in community acquired pneumonia: a validation study , 2000, Thorax.

[18]  Michael J Fine,et al.  Practice Guidelines for the Management of Community-Acquired Pneumonia in Adults , 2000, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[19]  M. Leinonen,et al.  role of serum troponin levels combined with electrocardiographic findings Study of community acquired pneumonia aetiology (SCAPA) in adults admitted to hospital: implications for management guidelines , 2001 .

[20]  W. Lim,et al.  Defining prognostic factors in the elderly with community acquired pneumonia: a case controlled study of patients aged > or = 75 yrs. , 2001, The European respiratory journal.

[21]  M. Fine,et al.  Guidelines for the management of adults with community-acquired pneumonia. Diagnosis, assessment of severity, antimicrobial therapy, and prevention. , 2001, American journal of respiratory and critical care medicine.